131 related articles for article (PubMed ID: 37743521)
21. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
22. Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling.
Song X; Wang Z; Liang H; Zhang W; Ye Y; Li H; Hu Y; Zhang Y; Weng H; Lu J; Wang X; Li M; Liu Y; Gu J
Int J Biol Sci; 2017; 13(6):782-793. PubMed ID: 28656003
[TBL] [Abstract][Full Text] [Related]
23. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Yang L; Wang H; Guo M; He M; Zhang W; Zhan M; Liu Y
Cell Oncol (Dordr); 2023 Aug; 46(4):1085-1095. PubMed ID: 36988891
[TBL] [Abstract][Full Text] [Related]
24. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
25. Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma.
Wang H; Luo QF; Peng AF; Long XH; Wang TF; Liu ZL; Zhang GM; Zhou RP; Gao S; Zhou Y; Chen WZ
Int J Mol Med; 2014 Mar; 33(3):633-9. PubMed ID: 24366211
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
[TBL] [Abstract][Full Text] [Related]
27. Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway.
Chuang HY; Lee YP; Lin WC; Lin YH; Hwang JJ
Sci Rep; 2019 Sep; 9(1):13284. PubMed ID: 31527721
[TBL] [Abstract][Full Text] [Related]
28. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
29. Pulsatilla saponin E suppresses viability, migration, invasion and promotes apoptosis of NSCLC cells through negatively regulating Akt/FASN pathway
Zhu M; Shi W; Chen K; Hu H; Ye X; Jiang Y
J Recept Signal Transduct Res; 2022 Feb; 42(1):23-33. PubMed ID: 33243063
[TBL] [Abstract][Full Text] [Related]
30. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
31. The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model.
Papaevangelou E; Almeida GS; Box C; deSouza NM; Chung YL
Int J Cancer; 2018 Aug; 143(4):992-1002. PubMed ID: 29569717
[TBL] [Abstract][Full Text] [Related]
32. FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1.
Ni J; Shang Y; Wang WD; Wang C; Wang AM; Li GJ; Chen SZ
Curr Mol Pharmacol; 2023; 16(7):771-786. PubMed ID: 36411574
[TBL] [Abstract][Full Text] [Related]
33. The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.
Agostini M; Almeida LY; Bastos DC; Ortega RM; Moreira FS; Seguin F; Zecchin KG; Raposo HF; Oliveira HC; Amoêdo ND; Salo T; Coletta RD; Graner E
Mol Cancer Ther; 2014 Mar; 13(3):585-95. PubMed ID: 24362464
[TBL] [Abstract][Full Text] [Related]
34. Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer.
Menendez JA; Mehmi I; Papadimitropoulou A; Vander Steen T; Cuyàs E; Verdura S; Espinoza I; Vellon L; Atlas E; Lupu R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081219
[TBL] [Abstract][Full Text] [Related]
35.
Tadros S; Shukla SK; King RJ; Gunda V; Vernucci E; Abrego J; Chaika NV; Yu F; Lazenby AJ; Berim L; Grem J; Sasson AR; Singh PK
Cancer Res; 2017 Oct; 77(20):5503-5517. PubMed ID: 28811332
[TBL] [Abstract][Full Text] [Related]
36. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
38. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer.
Han L; Dai W; Luo W; Ye L; Fang H; Mo S; Li Q; Xu Y; Wang R; Cai G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765520
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
[TBL] [Abstract][Full Text] [Related]
40. EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.
Zhang F; Xiang S; Cao Y; Li M; Ma Q; Liang H; Li H; Ye Y; Zhang Y; Jiang L; Hu Y; Zhou J; Wang X; Zhang Y; Nie L; Liang X; Gong W; Liu Y
Cell Death Dis; 2017 Jun; 8(6):e2868. PubMed ID: 28594409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
